Intended for healthcare professionals

General Practice

Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6977.441 (Published 18 February 1995) Cite this as: BMJ 1995;310:441
  1. L M Mynors-Wallis, consultant psychiatrista,
  2. D H Gath, clinical readera,
  3. A R Lloyd-Thomas, research general practitionera,
  4. D Tomlinson, research general practitionera
  1. a Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX
  1. Correspondence to: Dr Mynors-Wallis.
  • Accepted 12 January 1995

Abstract

Objective: To determine whether, in the treatment of major depression in primary care, a brief psychological treatment (problem solving) was (a) as effective as antidepressant drugs and more effective than placebo; (b) feasible in practice; and (c) acceptable to patients.

Design: Randomised controlled trial of problem solving treatment, amitriptyline plus standard clinical management, and drug placebo plus standard clinical management. Each treatment was delivered in six sessions over 12 weeks.

Setting: Primary care in Oxfordshire.

Subjects: 91 patients in primary care who had major depression.

Main outcome measures: Observer and self reported measures of severity of depression, self reported measure of social outcome, and observer measure of psychological symptoms at six and 12 weeks; self reported measure of patient satisfaction at 12 weeks. Numbers of patients recovered at six and 12 weeks.

Results: At six and 12 weeks the difference in score on the Hamilton rating scale for depression between problem solving and placebo treatments was significant (5.3 (95% confidence interval 1.6 to 9.0) and 4.7 (0.4 to 9.0) respectively), but the difference between problem solving and amitriptyline was not significant (1.8 (−1.8 to 5.5) and 0.9 (−3.3 to 5.2) respectively). At 12 weeks 60% (18/30) of patients given problem solving treatment had recovered on the Hamilton scale compared with 52% (16/31) given amitriptyline and 27% (8/30) given placebo. Patients were satisfied with problem solving treatment; all patients who completed treatment (28/30) rated the treatment as helpful or very helpful. The six sessions of problem solving treatment totalled a mean therapy time of 3 1/2 hours.

Conclusions: As a treatment for major depression in primary care, problem solving treatment is effective, feasible, and acceptable to patients.

Key messages

  • Key messages

  • Patient compliance with antidepressant treatment is often poor, so there is a need for a psychological treatment

  • This study found that problem solving is an effective psychological treatment for major depression in primary care—as effective as amitriptyline and more effective than placebo

  • Problem solving is a feasible treatment in primary care, being effective when given over six sessions by a general practitioner

  • Problem solving treatment is acceptable to patients

Footnotes

    • Accepted 12 January 1995
    View Full Text